Literature DB >> 565649

Retinal telangiectasis in adults: fluorescein angiographic findings and treatment by argon laser.

A Chopdar.   

Abstract

This article describes 3 cases of retinal telangiectasia, all presenting in middle age, affecting the macula. They have been investigated by means of fluorescein angiography and sucessfully treated by argon laser.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 565649      PMCID： PMC1043196          DOI： 10.1136/bjo.62.4.243

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


  2 in total

1.  Telangiectasis of the retina and Coats' disease.

Authors:  A B REESE
Journal:  Am J Ophthalmol       Date:  1956-07       Impact factor: 5.258

2.  Peripheral retinal angioma with exudative retinopathy in adults (coats's lesion).

Authors:  P Henkind; G Morgan
Journal:  Br J Ophthalmol       Date:  1966-01       Impact factor: 4.638
  2 in total
  8 in total

1.  Comparison of anatomical and visual outcomes following different anti-vascular endothelial growth factor treatments in subretinal neovascular membrane secondary to type 2 proliferative macular telangiectasia.

Authors:  Buğra Karasu; Betul Onal Gunay
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-11-25       Impact factor: 3.117

2.  Use of intravitreal bevacizumab injections to treat type 1 idiopathic macular telangiectasia.

Authors:  Byung Gil Moon; Yoon Jeon Kim; Young Hee Yoon; Joo Yong Lee
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-08-24       Impact factor: 3.117

3.  Intravitreal triamcinolone for management of idiopathic juxtafoveolar telangiectasis.

Authors:  Nitin Nema; Michael S Ip
Journal:  Oman J Ophthalmol       Date:  2010-01

4.  Idiopathic juxtafoveolar retinal telangiectasis: a current review.

Authors:  Sawsan R Nowilaty; Hanan N Al-Shamsi; Wajeeha Al-Khars
Journal:  Middle East Afr J Ophthalmol       Date:  2010-07

Review 5.  Macular telangiectasia type 2.

Authors:  Peter Charbel Issa; Mark C Gillies; Emily Y Chew; Alan C Bird; Tjebo F C Heeren; Tunde Peto; Frank G Holz; Hendrik P N Scholl
Journal:  Prog Retin Eye Res       Date:  2012-12-03       Impact factor: 21.198

6.  CLINICAL FEATURES OF TREATED AND UNTREATED TYPE 1 IDIOPATHIC MACULAR TELANGIECTASIA WITHOUT THE OCCURRENCE OF SECONDARY CHOROIDAL NEOVASCULARIZATION FOLLOWED FOR 2 YEARS IN JAPANESE PATIENTS.

Authors:  Rie Osaka; Chieko Shiragami; Aoi Ono; Mamoru Kobayashi; Yukari Takasago; Ayana Yamashita; Akitaka Tsujikawa
Journal:  Retina       Date:  2018-01       Impact factor: 4.256

7.  Pars plana vitrectomy combined with focal endolaser photocoagulation for idiopathic macular telangiectasia.

Authors:  Gaku Terauchi; Celso Soiti Matsumoto; Kei Shinoda; Harue Matsumoto; Yutaka Imamura; Emiko Watanabe; Takaaki Kondo; Atsushi Mizota
Journal:  Case Rep Med       Date:  2014-04-30

Review 8.  When is macular edema not macular edema? An update on macular telangiectasia type 2.

Authors:  Lihteh Wu
Journal:  Taiwan J Ophthalmol       Date:  2015-11-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.